AcelRx Pharmaceuticals

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute post-operative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Redwood City, California.
Company Growth (employees)
Type
Public
HQ
Redwood City, US
Size (employees)
39 (est)+9%
AcelRx Pharmaceuticals is headquartered in Redwood City, US

Key People at AcelRx Pharmaceuticals

Richard King

Richard King

President and CEO
James Welch

James Welch

CFO

AcelRx Pharmaceuticals Office Locations

AcelRx Pharmaceuticals has office in Redwood City
Redwood City, US

AcelRx Pharmaceuticals Metrics

AcelRx Pharmaceuticals Summary

Market capitalization

$138.3 m

Closing share price

$3.1
AcelRx Pharmaceuticals's current market capitalization is $138.3 m.

AcelRx Pharmaceuticals Financials

AcelRx Pharmaceuticals's revenue is $29.5 m in FY, 2013 which is a 465.5% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$29.5 m$5.2 m$19.3 m$17.4 m

Revenue growth, %

(82.3%)269.2%(9.9%)

Gross profit

$17.5 m

Operating expense total

$36.2 m$42.9 m$39.2 m

EBIT

($21.9 m)($30.7 m)($20 m)

Net Income

($23.4 m)($33.4 m)($24.4 m)($43.2 m)

Operating cash flow

$40.5 m($28.4 m)$47.9 m

AcelRx Pharmaceuticals Market Value History

We estimate that AcelRx Pharmaceuticals's current employees are approximately 22% female and 78% male.

AcelRx Pharmaceuticals Online Presence

AcelRx Pharmaceuticals News

AcelRx Pharmaceuticals Company Life

You may also be interested in